Hofseth BioCare Balance Sheet Health
Financial Health criteria checks 2/6
Hofseth BioCare has a total shareholder equity of NOK41.1M and total debt of NOK173.2M, which brings its debt-to-equity ratio to 420.9%. Its total assets and total liabilities are NOK390.1M and NOK349.0M respectively.
Key information
420.9%
Debt to equity ratio
kr173.16m
Debt
Interest coverage ratio | n/a |
Cash | kr23.89m |
Equity | kr41.14m |
Total liabilities | kr348.98m |
Total assets | kr390.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HOFB.F's short term assets (NOK131.0M) do not cover its short term liabilities (NOK251.9M).
Long Term Liabilities: HOFB.F's short term assets (NOK131.0M) exceed its long term liabilities (NOK97.1M).
Debt to Equity History and Analysis
Debt Level: HOFB.F's net debt to equity ratio (362.8%) is considered high.
Reducing Debt: HOFB.F's debt to equity ratio has increased from 47.3% to 420.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HOFB.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: HOFB.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.3% each year